Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$42.91
-4.43%
Mkt Cap $2.74B
Mkt Cap
$2.74B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.83
NASDAQ·Healthcare·Biotechnology
$42.91
-4.43%
Mkt Cap $2.74B
Mkt Cap
$2.74B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.83